Centene reports Q2 adjusted EPS $2.10, consensus $2.03

Reports Q2 revenue $37.61B, consensus $36.47B. “Our strong second quarter performance demonstrates Centene’s ability to deliver excellent financial results in a dynamic healthcare landscape. New business wins, strong Marketplace membership growth and continued advancement of our Value Creation Plan contributed to another solid quarter of execution. We are increasing our full year 2023 adjusted diluted EPS guidance, reflecting year-over-year growth of at least 12%, consistent with our long-term growth algorithm,” said CEO of Centene, Sarah London.